Mechanism of anti-angiogenic property of gold nanoparticles: Role of nanoparticle size and surface charge

Rochelle R. Arvizo, Subinoy Rana, Oscar R. Miranda, Resham Bhattacharya, Vincent M. Rotello, Priyabrata Mukherjee

Research output: Contribution to journalArticle

124 Citations (Scopus)

Abstract

Discovering therapeutic inorganic nanoparticles (NPs) is evolving as an important area of research in the emerging field of nanomedicine. Recently, we reported the anti-angiogenic property of gold nanoparticles (GNPs): It inhibits the function of pro-angiogenic heparin-binding growth factors (HB-GFs), such as vascular endothelial growth factor 165 (VEGF165) and basic fibroblast growth factor (bFGF), etc. However, the mechanism through which GNPs imparts such an effect remains to be investigated. Using GNPs of different sizes and surface charges, we demonstrate here that a naked GNP surface is required and core size plays an important role to inhibit the function of HB-GFs and subsequent intracellular signaling events. We also demonstrate that the inhibitory effect of GNPs is due to the change in HB-GFs conformation/configuration (denaturation) by the NPs, whereas the conformations of non-HB-GFs remain unaffected. We believe that this significant study will help structure-based design of therapeutic NPs to inhibit the functions of disease-causing proteins. From the Clinical Editor: In this landmark paper by Arvizo and colleagues, the angiogenesis inhibitor effects of gold nanoparticles were investigated as the function of size and charge. This study will pave the way to the development of therapeutic NPs that inhibit the functions of pathogenic proteins.

Original languageEnglish (US)
Pages (from-to)580-587
Number of pages8
JournalNanomedicine: Nanotechnology, Biology, and Medicine
Volume7
Issue number5
DOIs
StatePublished - Oct 2011

Fingerprint

Surface charge
Gold
Nanoparticles
Intercellular Signaling Peptides and Proteins
Heparin
Conformations
Nanomedicine
Proteins
Medical nanotechnology
Denaturation
Angiogenesis Inhibitors
Angiogenesis Inducing Agents
Fibroblast Growth Factor 2
Fibroblasts
Therapeutics

Keywords

  • Angiogenesis
  • Gold nanoparticles
  • Protein conformation
  • VEGF165

ASJC Scopus subject areas

  • Molecular Medicine
  • Bioengineering
  • Biomedical Engineering
  • Materials Science(all)
  • Medicine (miscellaneous)
  • Pharmaceutical Science

Cite this

Mechanism of anti-angiogenic property of gold nanoparticles : Role of nanoparticle size and surface charge. / Arvizo, Rochelle R.; Rana, Subinoy; Miranda, Oscar R.; Bhattacharya, Resham; Rotello, Vincent M.; Mukherjee, Priyabrata.

In: Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 7, No. 5, 10.2011, p. 580-587.

Research output: Contribution to journalArticle

Arvizo, Rochelle R. ; Rana, Subinoy ; Miranda, Oscar R. ; Bhattacharya, Resham ; Rotello, Vincent M. ; Mukherjee, Priyabrata. / Mechanism of anti-angiogenic property of gold nanoparticles : Role of nanoparticle size and surface charge. In: Nanomedicine: Nanotechnology, Biology, and Medicine. 2011 ; Vol. 7, No. 5. pp. 580-587.
@article{d999e64efa684e63bf2c048679e04621,
title = "Mechanism of anti-angiogenic property of gold nanoparticles: Role of nanoparticle size and surface charge",
abstract = "Discovering therapeutic inorganic nanoparticles (NPs) is evolving as an important area of research in the emerging field of nanomedicine. Recently, we reported the anti-angiogenic property of gold nanoparticles (GNPs): It inhibits the function of pro-angiogenic heparin-binding growth factors (HB-GFs), such as vascular endothelial growth factor 165 (VEGF165) and basic fibroblast growth factor (bFGF), etc. However, the mechanism through which GNPs imparts such an effect remains to be investigated. Using GNPs of different sizes and surface charges, we demonstrate here that a naked GNP surface is required and core size plays an important role to inhibit the function of HB-GFs and subsequent intracellular signaling events. We also demonstrate that the inhibitory effect of GNPs is due to the change in HB-GFs conformation/configuration (denaturation) by the NPs, whereas the conformations of non-HB-GFs remain unaffected. We believe that this significant study will help structure-based design of therapeutic NPs to inhibit the functions of disease-causing proteins. From the Clinical Editor: In this landmark paper by Arvizo and colleagues, the angiogenesis inhibitor effects of gold nanoparticles were investigated as the function of size and charge. This study will pave the way to the development of therapeutic NPs that inhibit the functions of pathogenic proteins.",
keywords = "Angiogenesis, Gold nanoparticles, Protein conformation, VEGF165",
author = "Arvizo, {Rochelle R.} and Subinoy Rana and Miranda, {Oscar R.} and Resham Bhattacharya and Rotello, {Vincent M.} and Priyabrata Mukherjee",
year = "2011",
month = "10",
doi = "10.1016/j.nano.2011.01.011",
language = "English (US)",
volume = "7",
pages = "580--587",
journal = "Nanomedicine: Nanotechnology, Biology, and Medicine",
issn = "1549-9634",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Mechanism of anti-angiogenic property of gold nanoparticles

T2 - Role of nanoparticle size and surface charge

AU - Arvizo, Rochelle R.

AU - Rana, Subinoy

AU - Miranda, Oscar R.

AU - Bhattacharya, Resham

AU - Rotello, Vincent M.

AU - Mukherjee, Priyabrata

PY - 2011/10

Y1 - 2011/10

N2 - Discovering therapeutic inorganic nanoparticles (NPs) is evolving as an important area of research in the emerging field of nanomedicine. Recently, we reported the anti-angiogenic property of gold nanoparticles (GNPs): It inhibits the function of pro-angiogenic heparin-binding growth factors (HB-GFs), such as vascular endothelial growth factor 165 (VEGF165) and basic fibroblast growth factor (bFGF), etc. However, the mechanism through which GNPs imparts such an effect remains to be investigated. Using GNPs of different sizes and surface charges, we demonstrate here that a naked GNP surface is required and core size plays an important role to inhibit the function of HB-GFs and subsequent intracellular signaling events. We also demonstrate that the inhibitory effect of GNPs is due to the change in HB-GFs conformation/configuration (denaturation) by the NPs, whereas the conformations of non-HB-GFs remain unaffected. We believe that this significant study will help structure-based design of therapeutic NPs to inhibit the functions of disease-causing proteins. From the Clinical Editor: In this landmark paper by Arvizo and colleagues, the angiogenesis inhibitor effects of gold nanoparticles were investigated as the function of size and charge. This study will pave the way to the development of therapeutic NPs that inhibit the functions of pathogenic proteins.

AB - Discovering therapeutic inorganic nanoparticles (NPs) is evolving as an important area of research in the emerging field of nanomedicine. Recently, we reported the anti-angiogenic property of gold nanoparticles (GNPs): It inhibits the function of pro-angiogenic heparin-binding growth factors (HB-GFs), such as vascular endothelial growth factor 165 (VEGF165) and basic fibroblast growth factor (bFGF), etc. However, the mechanism through which GNPs imparts such an effect remains to be investigated. Using GNPs of different sizes and surface charges, we demonstrate here that a naked GNP surface is required and core size plays an important role to inhibit the function of HB-GFs and subsequent intracellular signaling events. We also demonstrate that the inhibitory effect of GNPs is due to the change in HB-GFs conformation/configuration (denaturation) by the NPs, whereas the conformations of non-HB-GFs remain unaffected. We believe that this significant study will help structure-based design of therapeutic NPs to inhibit the functions of disease-causing proteins. From the Clinical Editor: In this landmark paper by Arvizo and colleagues, the angiogenesis inhibitor effects of gold nanoparticles were investigated as the function of size and charge. This study will pave the way to the development of therapeutic NPs that inhibit the functions of pathogenic proteins.

KW - Angiogenesis

KW - Gold nanoparticles

KW - Protein conformation

KW - VEGF165

UR - http://www.scopus.com/inward/record.url?scp=80053180372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053180372&partnerID=8YFLogxK

U2 - 10.1016/j.nano.2011.01.011

DO - 10.1016/j.nano.2011.01.011

M3 - Article

C2 - 21333757

AN - SCOPUS:80053180372

VL - 7

SP - 580

EP - 587

JO - Nanomedicine: Nanotechnology, Biology, and Medicine

JF - Nanomedicine: Nanotechnology, Biology, and Medicine

SN - 1549-9634

IS - 5

ER -